Targeted delivery of epirubicin to cancerous cell using copper sulphide nanoparticle coated with polyarginine and 5TR1 aptamer

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

J‐aggregate‐based FRET monitoring of drug release from polymer nanoparticles with high drug loading

(2020) Yun Liu et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy

(2020) Zhaoying Fu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice

(2019) Laboni Mondal et al.   International Journal of Nanomedicine

Multifaceted NIR-responsive polymer-peptide-enveloped drug-loaded copper sulfide nanoplatform for chemo-phototherapy against highly tumorigenic prostate cancer

(2019) Kishwor Poudel et al.   Nanomedicine-Nanotechnology Biology and Medicine

Chemotherapeutic agents for the treatment of metastatic breast cancer: An update

(2018) Mariam Abotaleb et al.   BIOMEDICINE & PHARMACOTHERAPY

Targeted co-delivery of epirubicin and NAS-24 aptamer to cancer cells using selenium nanoparticles for enhancing tumor response in vitro and in vivo

(2018) Seyed Hamid Jalalian et al.   CANCER LETTERS

Targeting luteinizing hormone-releasing hormone: A potential therapeutics to treat gynecological and other cancers

(2018) Raksha Ghanghoria et al.   JOURNAL OF CONTROLLED RELEASE

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization

(2018) Susan Hua et al.   Frontiers in Pharmacology

Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: A cross-sectional study

(2017) Liselotte M. Boerman et al.   EUROPEAN JOURNAL OF CANCER

The use of functional epirubicin liposomes to induce programmed death in refractory breast cancer

(2017) Lei Liu et al.   International Journal of Nanomedicine

Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy

(2017) Jing Zhang et al.   International Journal of Nanomedicine

Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer

(2017) Chunlai Feng et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy

(2017) Yin Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Treatment outcome comparisons between exons 19 and 21 EGFR mutations for non-small-cell lung cancer patients with malignant pleural effusion after first-line and second-line tyrosine kinase inhibitors

(2017) Zhen Zheng et al.   TUMOR BIOLOGY

MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma

(2017) Yin-Ping Fan et al.   Molecular Therapy-Nucleic Acids

Review of hematological indices of cancer patients receiving combined chemotherapy & radiotherapy or receiving radiotherapy alone

(2016) Saman Shahid   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo

(2016) Seyed Mohammad Taghdisi et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Targeted Delivery of Epirubicin to Cancer Cells by Polyvalent Aptamer System in vitro and in vivo

(2016) Rezvan Yazdian-Robati et al.   PHARMACEUTICAL RESEARCH

Evaluating Hepatitis B Virus Reactivation During Solid Tumor Chemotherapy: Evidence to Guide Pretreatment Hepatitis B Screening and Prophylaxis

(2015) Vincent Lo Re et al.   ANNALS OF INTERNAL MEDICINE

Dual Protective and Cytotoxic Benefits of Mesenchymal Stem Cell Therapy in Combination with Chemotherapy/Radiotherapy for Cancer Patients

(2015) Fatemeh Hendijani et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo

(2013) Seyed Hamid Jalalian et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide

(2012) Jagat R. Kanwar et al.   ANTI-CANCER DRUGS

The Possible “Proton Sponge ” Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pH

(2012) Rikke V Benjaminsen et al.   MOLECULAR THERAPY

The Ligand Nanoparticle Conjugation Approach for Targeted Cancer Therapy

(2011) Nour Karra et al.   CURRENT DRUG METABOLISM

Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles

(2010) Chunbai He et al.   BIOMATERIALS

Role of Anthracyclines in the Treatment of Early Breast Cancer

(2009) Luca Gianni et al.   JOURNAL OF CLINICAL ONCOLOGY